Kidder Stephen W - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,008 filers reported holding NOVARTIS A G in Q4 2017. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.

Quarter-by-quarter ownership
Kidder Stephen W ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$2,838,329
+0.2%
27,865
-0.8%
0.98%
+6.1%
Q2 2023$2,834,058
+10.0%
28,085
+0.3%
0.93%
+3.5%
Q1 2023$2,575,540
-2.4%
27,995
-3.8%
0.90%
-7.2%
Q4 2022$2,639,498
+19.3%
29,095
-0.0%
0.97%
+7.1%
Q3 2022$2,213,000
-16.3%
29,105
-7.0%
0.90%
-11.8%
Q2 2022$2,644,000
-25.0%
31,280
-22.2%
1.02%
-10.1%
Q1 2022$3,526,000
-5.7%
40,192
-6.0%
1.14%
+0.3%
Q4 2021$3,739,000
-19.3%
42,745
-24.6%
1.14%
-21.8%
Q3 2021$4,634,000
-19.6%
56,668
-10.3%
1.45%
-18.3%
Q2 2021$5,767,000
-3.4%
63,205
-9.4%
1.78%
-7.7%
Q1 2021$5,967,000
-15.0%
69,791
-6.2%
1.93%
-17.5%
Q4 2020$7,023,000
+6.4%
74,371
-2.0%
2.34%
-0.2%
Q3 2020$6,602,000
-0.9%
75,921
-0.5%
2.34%
-7.8%
Q2 2020$6,662,000
+6.0%
76,281
+0.1%
2.54%
-10.9%
Q1 2020$6,282,000
-13.9%
76,186
-1.2%
2.85%
+6.2%
Q4 2019$7,300,000
+6.8%
77,093
-2.0%
2.69%
-0.3%
Q3 2019$6,835,000
-2.7%
78,671
+2.3%
2.69%
-4.3%
Q2 2019$7,024,000
-6.4%
76,926
-1.5%
2.81%
-7.7%
Q1 2019$7,507,000
+3.3%
78,078
-7.8%
3.05%
-4.8%
Q4 2018$7,268,000
-2.4%
84,698
-2.0%
3.20%
+17.8%
Q3 2018$7,450,000
+12.1%
86,454
-1.7%
2.72%
+6.7%
Q2 2018$6,644,000
-5.4%
87,954
+1.2%
2.55%
-5.0%
Q1 2018$7,024,000
-7.2%
86,874
-3.6%
2.68%
-1.1%
Q4 2017$7,565,000
-1.3%
90,097
+0.9%
2.71%
-4.0%
Q3 2017$7,668,000
+3.1%
89,308
+0.2%
2.82%
+0.2%
Q2 2017$7,440,000
+12.3%
89,148
-0.0%
2.82%
+10.6%
Q1 2017$6,624,000
+5.6%
89,187
+3.5%
2.55%
+0.3%
Q4 2016$6,273,000
-10.3%
86,142
-2.7%
2.54%
-8.6%
Q3 2016$6,990,000
-6.0%
88,522
-1.7%
2.78%
-6.1%
Q2 2016$7,433,000
+16.2%
90,077
+2.0%
2.96%
+14.0%
Q1 2016$6,398,000
-8.0%
88,322
+9.3%
2.60%
-12.7%
Q4 2015$6,953,000
+4.6%
80,817
+11.8%
2.97%
-10.7%
Q3 2015$6,646,000
-6.6%
72,302
-0.1%
3.33%
+3.7%
Q2 2015$7,114,000
-0.6%
72,342
-0.4%
3.21%
+3.6%
Q1 2015$7,160,000
+7.6%
72,607
+1.1%
3.10%
+7.4%
Q4 2014$6,655,000
+1.5%
71,822
+3.1%
2.88%
-3.2%
Q3 2014$6,559,000
+22.5%
69,687
+17.8%
2.98%
-16.2%
Q2 2014$5,355,000
+5.6%
59,147
-0.9%
3.56%
+4.2%
Q1 2014$5,073,000
+4.0%
59,657
-1.7%
3.41%
+1.8%
Q4 2013$4,877,000
+1.4%
60,682
-3.3%
3.35%
-9.7%
Q3 2013$4,811,000
+5.5%
62,732
-2.7%
3.71%
+1.1%
Q2 2013$4,561,000
+12.6%
64,498
+0.8%
3.67%
+3.2%
Q4 2012$4,052,00064,0083.56%
Other shareholders
NOVARTIS A G shareholders Q4 2017
NameSharesValueWeighting ↓
MANAGED ASSET PORTFOLIOS, LLC 335,936$29,213,0005.81%
Martin Investment Management, LLC 170,759$14,849,0005.36%
Mawer Investment Management Ltd. 8,515,391$740,498,0004.84%
SCHARF INVESTMENTS, LLC 1,212,354$105,426,0004.54%
Hansberger Growth Investors, LP 45,645$3,969,0004.50%
GARLAND CAPITAL MANAGEMENT INC 50,905$4,427,0003.95%
First Fiduciary Investment Counsel, Inc. 193,021$16,785,0003.49%
PROFESSIONAL ADVISORY SERVICES INC 224,087$19,487,0003.48%
WOODLEY FARRA MANION PORTFOLIO MANAGEMENT INC 362,047$31,484,0003.29%
WILKINS INVESTMENT COUNSEL INC 126,470$10,998,0003.28%
View complete list of NOVARTIS A G shareholders